贵阳朗玛信息技术股份有限公司 2019 年第一季度报告全文 贵阳朗玛信息技术股份有限公司 2019 年第一季度报告 2019 年 04 月 1 贵阳朗玛信息技术股份有限公司 2019 年第一季度报告全文 第一节 重要提示 2 贵阳朗玛信息技术股份有限公司 2019 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期 | | --- | --- | --- | --- | | | | | 增减 | | 营业总收入（元） | 115,110,413.66 | 105,717,302.57 | 8.89% | | 归属于上市公司股东的净利润 | 18,952,556.07 | 21,472,892.33 | -11.74% | | （元） | | | | | 归属于上市公司股东的扣除非经 | 18,189,142.46 | 20,299,681.77 | -10.40% | | 常性损益的净利润（元） | | | | | 经营活动产生的现金流量净额 | 29,364,134.90 | ...

贵阳朗玛信息技术股份有限公司 2018 年年度报告全文 贵阳朗玛信息技术股份有限公司 2018 年年度报告 2019 年 04 月 1 贵阳朗玛信息技术股份有限公司 2018 年年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连 带的法律责任。 公司负责人王伟、主管会计工作负责人王春及会计机构负责人(会计主管人 员)马勇声明：保证年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本报告中如有涉及未来的计划、业绩预测等方面的内容，均不构成本公司 对任何投资者及相关人士的承诺。投资者及相关人士均应对此保持足够的风险 认识，并且应当理解计划、预测与承诺之间的差异。公司在本报告第四节"经 营情况讨论与分析"之"九、公司未来发展的展望"部分，详细描述了公司经 营中可能存在的风险，敬请投资者关注相关内容，注意投资风险。 公司目前不存在影响公司正常经营的重大风险。 公司经本次董事会审议通过的利润分配预案为：以 337,941,402 为基数， 向全体股东每 10 ...

贵阳朗玛信息技术股份有限公司 2018 年半年度报告全文 贵阳朗玛信息技术股份有限公司 2018 年半年度报告 2018 年 08 月 1 贵阳朗玛信息技术股份有限公司 2018 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的 真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别 和连带的法律责任。 公司负责人王伟、主管会计工作负责人王春及会计机构负责人(会计主管人 员)马勇声明：保证本半年度报告中财务报告的真实、准确、完整。 除下列董事外，其他董事亲自出席了审议本次半年报的董事会会议 | 未亲自出席董事姓名 | 未亲自出席董事职务 | 未亲自出席会议原因 | 被委托人姓名 | | --- | --- | --- | --- | | 刘景伟 | 独立董事 | 因公出差 | 王迅 | 本报告中如有涉及未来的计划、业绩预测等方面的内容，均不构成本公司 对任何投资者及相关人士的承诺。投资者及相关人士均应对此保持足够的风险 认识，并且应当理解计划、预测与承诺之间的差异。公司在本报告第四节"经营 情况讨论与分析"之"十、公司面临的风险和应 ...

2018 年第三季度报告 2018 年 10 月 1 贵阳朗玛信息技术股份有限公司 2018 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 贵阳朗玛信息技术股份有限公司 2018 年第三季度报告全文 贵阳朗玛信息技术股份有限公司 所有董事均已出席了审议本次季报的董事会会议。 公司负责人王伟、主管会计工作负责人王春及会计机构负责人(会计主管人 员)马勇声明：保证季度报告中财务报表的真实、准确、完整。 2 贵阳朗玛信息技术股份有限公司 2018 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末 | | --- | --- | --- | --- | --- | | | | | | 增减 | | 总资产（元） | 1,721,743,737.33 | | 1,528,184,542.05 | 12.67% | | 归属于上市公司股东 ...

[Part I: Important Notice, Table of Contents, and Definitions](index=2&type=section&id=Part%20I%3A%20Important%20Notice%2C%20Table%20of%20Contents%2C%20and%20Definitions) This section provides important disclaimers, the report's table of contents, and definitions of key terms used throughout the document [Important Notice](index=2&type=section&id=Important%20Notice) The company's management guarantees the truthfulness, accuracy, and completeness of this semi-annual report, with future plans not constituting substantive commitments, and no profit distribution planned - The company's board of directors, supervisory board, and senior management guarantee the truthfulness, accuracy, and completeness of the report content and assume legal responsibility[3](index=3&type=chunk) - The company plans not to distribute cash dividends, bonus shares, or convert capital reserves into share capital[6](index=6&type=chunk) [Table of Contents](index=3&type=section&id=Table%20of%20Contents) This report comprises eleven chapters covering company profile, business overview, operational performance, significant matters, and financial reports [Definitions](index=4&type=section&id=Definitions) This chapter defines key terms used in the report, including company and business entities like "39 Internet Hospital" and "Liuyi Company," as well as technical terms such as "IPTV" and "EPG" - The reporting period refers to January 1, 2018, to June 30, 2018[11](index=11&type=chunk) [Part II: Company Profile and Key Financial Indicators](index=5&type=section&id=Part%20II%3A%20Company%20Profile%20and%20Key%20Financial%20Indicators) This section presents the company's basic information and a summary of its key financial performance metrics [Company Profile](index=5&type=section&id=Company%20Profile) Guiyang Langma Information Technology Co., Ltd. (stock code: 300288) is listed on the Shenzhen Stock Exchange, with Wang Wei as its legal representative, and no significant changes in information disclosure or contact details during the reporting period | Item | Content | | :--- | :--- | | Stock Abbreviation | Langma Information | | Stock Code | 300288 | | Listing Exchange | Shenzhen Stock Exchange | | Legal Representative | Wang Wei | [Key Accounting Data and Financial Indicators](index=6&type=section&id=Key%20Accounting%20Data%20and%20Financial%20Indicators) In the first half of 2018, the company achieved total operating revenue of **228.47 million yuan**, a 10.06% year-on-year increase, with net profit attributable to shareholders reaching **50.13 million yuan**, up 2.38% | Key Financial Indicators | Current Reporting Period | Prior Year Period | Year-on-Year Change | | :--- | :--- | :--- | :--- | | Total Operating Revenue (yuan) | 228,472,570.81 | 207,584,113.81 | 10.06% | | Net Profit Attributable to Shareholders (yuan) | 50,134,370.92 | 48,968,125.68 | 2.38% | | Net Profit After Non-Recurring Items (yuan) | 45,049,662.52 | 46,970,670.25 | -4.09% | | Net Cash Flow from Operating Activities (yuan) | 42,348,247.01 | 40,160,073.06 | 5.45% | | Basic Earnings Per Share (yuan/share) | 0.15 | 0.14 | 7.14% | | Total Assets (yuan) | 1,593,309,463.46 | 1,528,184,542.05 | 4.26% (vs. end of prior year) | | Net Assets Attributable to Shareholders (yuan) | 1,260,131,055.23 | 1,212,028,171.21 | 3.97% (vs. end of prior year) | [Non-Recurring Gains and Losses Items and Amounts](index=7&type=section&id=Non-Recurring%20Gains%20and%20Losses%20Items%20and%20Amounts) During the reporting period, the company's non-recurring gains and losses totaled **5.08 million yuan**, primarily from government subsidies of **5.54 million yuan** recognized in current profit or loss | Item | Amount (yuan) | Explanation | | :--- | :--- | :--- | | Government Subsidies | 5,538,322.00 | Primarily allocation of prior government subsidies and new subsidies received in the current period | | Debt Restructuring Gains/Losses | 197,082.37 | Liuyi Company obtained creditor waivers | | Net Other Non-Operating Income/Expenses | 607,336.03 | - | | **Total Non-Recurring Gains and Losses** | **5,084,708.40** | - | [Part III: Company Business Overview](index=9&type=section&id=Part%20III%3A%20Company%20Business%20Overview) This section outlines the company's core business segments, significant asset changes, and key competitive advantages [Main Businesses During the Reporting Period](index=9&type=section&id=Main%20Businesses%20During%20the%20Reporting%20Period) The company's main operations are divided into two major segments: "Healthcare + Internet Healthcare" and "Telecom Value-Added Services," with the healthcare segment establishing a comprehensive internet healthcare ecosystem and the telecom segment providing stable cash flow - **Healthcare + Internet Healthcare Business Segment Layout:** * **Medical Information Services**: Provides online medical information through 39 Health Network, monetized via advertising * **Medical Services**: Operates through Guiyang Sixth People's Hospital, combined with "39 Internet Hospital" and "Guizhou (Guiyang) Internet Hospital" for remote consultations and tiered diagnosis and treatment * **IPTV Business**: Integrates internet hospital services into the IPTV platform, promoted in collaboration with telecom operators * **Pharmaceutical Distribution**: Conducts pharmaceutical wholesale and distribution through its e-commerce subsidiary (Kangxin Pharmaceutical) * **Smart Wearable Devices**: Develops wearable devices for chronic disease management to complete closed-loop services[27](index=27&type=chunk)[28](index=28&type=chunk)[29](index=29&type=chunk)[30](index=30&type=chunk) - **Telecom Value-Added Services Segment:** * **Phone Matchmaking**: Provides voice social entertainment services, serving as a stable cash flow source for the company * **Mobile Resale Business**: Collaborates with basic operators to provide mobile communication services, currently applying for a formal license[31](index=31&type=chunk)[32](index=32&type=chunk) [Significant Changes in Major Assets](index=11&type=section&id=Significant%20Changes%20in%20Major%20Assets) During the reporting period, the company experienced significant increases in construction in progress, prepayments, other receivables, and other current assets, primarily due to investments in Liuyi Company's construction projects and prepaid engineering costs | Major Asset | Year-on-Year Growth Rate | Primary Reason | | :--- | :--- | :--- | | Construction in Progress | 108.36% | Investment in Liuyi Company's construction projects | | Prepayments | 134.92% | Prepaid construction costs by Liuyi Company | | Other Receivables | 158.48% | Payment of a **5 million yuan** mobile resale business deposit | | Other Current Assets | 113.51% | Prepaid corporate income tax and deductible input VAT | | Long-Term Deferred Expenses | 409.53% | Factory renovation expenses incurred from the merger of Guizhou Laya | [Analysis of Core Competencies](index=11&type=section&id=Analysis%20of%20Core%20Competencies) The company's core competencies span multiple areas, including policy support, professional teams, medical resources, and technological advantages in internet healthcare, alongside network scale and content advantages in information services, and robust distribution and innovation in telecom value-added services - **Internet Healthcare and Medical Services Competitiveness:** * Respects the essence of healthcare, utilizing the internet as a connector and amplifier * Receives strong policy support from Guizhou Province for big data and big health industries * Possesses a composite team integrating medical industry experts with internet operation experience * Accumulated high-quality medical resources and advantages in audio-video communication technology[34](index=34&type=chunk)[35](index=35&type=chunk)[36](index=36&type=chunk) - **Other Business Competitiveness:** * **Internet Information Services**: 39 Health Network, as a leading domestic health portal, boasts advantages in content, partnership resources, and talent * **Pharmaceutical Distribution**: Features a "deep, wide, and high" marketing channel network and efficient logistics * **Voice Value-Added Services**: Relies on independent innovation, long-term cooperation with operators, and a comprehensive service system[36](index=36&type=chunk)[37](index=37&type=chunk)[38](index=38&type=chunk)[39](index=39&type=chunk) [Part IV: Discussion and Analysis of Operations](index=14&type=section&id=Part%20IV%3A%20Discussion%20and%20Analysis%20of%20Operations) This section provides an in-depth discussion of the company's operational performance, including revenue analysis, asset and liability status, investment activities, and risk management strategies [Overview](index=14&type=section&id=Overview) In the first half of 2018, the company steadily advanced its various businesses, re-entering the "Top 100 Chinese Internet Enterprises" at 39th place, and further refined its internet healthcare ecosystem with progress across all segments - The company was once again selected among the "2018 Top 100 Chinese Internet Enterprises," ranking 39th, making it the only "Internet + Healthcare" enterprise to be included for three consecutive years[42](index=42&type=chunk) [39 Health Network](index=14&type=section&id=39%20Health%20Network) As a core medical information platform, 39 Health Network achieved **76.02 million yuan** in operating revenue and **42.24 million yuan** in net profit during the reporting period, with monthly user coverage exceeding **400 million** and successful commercialization breakthroughs | Business Segment | Performance in Reporting Period | | :--- | :--- | | Operating Revenue | 76.02 million yuan | | Net Profit | 42.24 million yuan | - All-channel traffic grew steadily, with monthly coverage exceeding **400 million** unique visitors[44](index=44&type=chunk) [Physical Hospitals](index=15&type=section&id=Physical%20Hospitals) As a core component of the "Internet + Healthcare" strategy, Liuyi Company's operations continued to improve, achieving **83.77 million yuan** in revenue in the first half of 2018, a 37.46% year-on-year increase, while continuously attracting talent and enhancing specialized medical capabilities - In the first half of 2018, revenue reached **83.77 million yuan**, a 37.46% year-on-year increase[48](index=48&type=chunk) - In the first half of the year, **9** new talents with associate senior titles or master's degrees or above were introduced, continuously strengthening the medical service team[46](index=46&type=chunk) [39 Internet Hospital](index=16&type=section&id=39%20Internet%20Hospital) The 39 Internet Hospital, centered on the "doctor-to-doctor consultation" model, serves grassroots medical institutions through remote consultations and teaching rounds, having partnered with nearly **300** medical institutions and over **2,000** experts, with significant year-on-year growth in consultation revenue and volume - Has partnered with nearly **300** medical institutions and signed expert teams exceeding **2,000** members, covering **24** provinces nationwide[51](index=51&type=chunk) [Guizhou (Guiyang) Internet Hospital](index=17&type=section&id=Guizhou%20(Guiyang)%20Internet%20Hospital) This platform provides decentralized medical services to grassroots communities, with a cumulative consultation volume of nearly **2 million** visits, over **1 million** registered users, and a daily consultation volume of **6,000** visits, while its mobile app "Gui Health" has integrated with the registration platforms of nearly **200** hospitals in the province - Cumulative consultation volume reached nearly **2 million** visits, registered users exceeded **1 million**, and daily consultation volume reached **6,000** visits[52](index=52&type=chunk) [IPTV Business](index=18&type=section&id=IPTV%20Business) During the reporting period, the company's IPTV smart healthcare family health service platform officially launched, now available on multiple provincial platforms of China Unicom and China Telecom, as well as Guizhou Radio and Television, offering chronic disease management and health consultation services to TV users - Business launch has been completed for China Unicom (Tianjin TV Center), China Telecom (Jiangsu Base), Anhui Telecom, Qinghai Telecom, and Guizhou Radio and Television[55](index=55&type=chunk) [Pharmaceutical Distribution Sector](index=18&type=section&id=Pharmaceutical%20Distribution%20Sector) The pharmaceutical e-commerce subsidiary, the largest pharmaceutical wholesale and distribution enterprise in Guizhou Province, achieved **1.79 billion yuan** in consolidated sales including tax and **1.57 billion yuan** in operating revenue during the reporting period, with its sales network covering all of Guizhou Province and parts of surrounding areas | Business Segment | Performance in Reporting Period | | :--- | :--- | | Consolidated Sales (including tax) | 1.79 billion yuan | | Operating Revenue | 1.57 billion yuan | [Smart Wearable Device Business](index=18&type=section&id=Smart%20Wearable%20Device%20Business) The smart wearable device business, managed by Guizhou Laya, focuses on R&D and production of POCT devices (e.g., blood glucose, uric acid monitoring) to meet grassroots medical and home health management needs, with initial R&D completed and production facilities ready for operation - Guizhou Laya has completed preliminary R&D, and the production workshop has passed cleanliness inspections, meeting production readiness conditions[58](index=58&type=chunk) [Phone Matchmaking](index=19&type=section&id=Phone%20Matchmaking) As the company's traditional telecom value-added service, the "Phone Matchmaking" voice social platform maintained stable user stickiness, generating **45.42 million yuan** in revenue during the reporting period and providing stable cash flow for the company - Achieved **45.42 million yuan** in revenue during the reporting period[59](index=59&type=chunk) [Mobile Resale Business](index=19&type=section&id=Mobile%20Resale%20Business) The mobile resale business has transitioned to formal commercial operation, with the company currently applying for a formal license; as of June 2018, it had accumulated over **2 million** users across more than **60** cities, generating **21.59 million yuan** in revenue in the first half of the year - Accumulated over **2 million** users and achieved **21.59 million yuan** in revenue in the first half of the year[60](index=60&type=chunk)[61](index=61&type=chunk) [Analysis of Main Business](index=20&type=section&id=Analysis%20of%20Main%20Business) During the reporting period, the company's operating revenue increased by 10.06%, while operating costs rose by 14.86%, leading to a slight decrease in gross profit margin; medical services revenue grew fastest at 35.60%, and mobile resale business saw a significant gross profit margin increase of 20.62 percentage points | Product or Service | Operating Revenue (yuan) | Operating Cost (yuan) | Gross Profit Margin | YoY Change in Operating Revenue | YoY Change in Operating Cost | YoY Change in Gross Profit Margin | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Phone Matchmaking & Coins | 45,417,492.72 | 4,556,798.10 | 89.97% | -11.47% | -1.85% | -0.98% | | Mobile Resale Business | 21,594,806.27 | 15,557,792.10 | 27.96% | 4.27% | -18.93% | 20.62% | | Medical Information Services | 74,096,021.07 | 11,656,422.39 | 84.27% | 6.44% | -20.25% | 5.27% | | Medical Services | 82,579,749.16 | 73,664,226.78 | 10.80% | 35.60% | 31.45% | 2.82% | [Analysis of Non-Core Business](index=21&type=section&id=Analysis%20of%20Non-Core%20Business) During the reporting period, the impact of non-core businesses on profit primarily stemmed from investment income of **8.94 million yuan**, accounting for 16.05% of total profit, mainly from equity-accounted associate companies and deemed sustainable, alongside **3.54 million yuan** in other income from government subsidies | Item | Amount (yuan) | Percentage of Total Profit | Reason for Formation | | :--- | :--- | :--- | :--- | | Investment Income | 8,941,208.37 | 16.05% | Primarily investment income from equity-accounted associate companies | | Non-Operating Income | 3,456,005.26 | 6.20% | Primarily government subsidies unrelated to daily operations | | Other Income | 3,538,322.00 | 6.35% | Primarily government subsidies related to daily operations | [Analysis of Assets and Liabilities](index=21&type=section&id=Analysis%20of%20Assets%20and%20Liabilities) As of the end of the reporting period, the company's total assets stood at **1.59 billion yuan**, with construction in progress increasing from 3.76% to 7.52% of total assets, mainly due to increased investment in Liuyi Company's medical technology and inpatient comprehensive building project | Asset Item | Period-End Balance (yuan) | Percentage of Total Assets | Period-Beginning Balance (yuan) | Percentage of Total Assets | Change in Proportion | | :--- | :--- | :--- | :--- | :--- | :--- | | Monetary Funds | 240,884,567.48 | 15.12% | 274,856,054.24 | 17.99% | -2.87% | | Long-Term Equity Investments | 273,372,928.98 | 17.16% | 283,149,638.35 | 18.53% | -1.37% | | Fixed Assets | 165,127,992.28 | 10.36% | 168,784,456.74 | 11.04% | -0.68% | | Construction in Progress | 119,748,203.09 | 7.52% | 57,472,611.56 | 3.76% | 3.76% | [Analysis of Investment Status](index=22&type=section&id=Analysis%20of%20Investment%20Status) During the reporting period, the company's investment amounted to **21.39 million yuan**, a 397.33% year-on-year increase, with significant equity investments including the acquisition and capital increase of 80% equity in Guizhou Laya Technology Co., Ltd., and the establishment of Guiyang Langma Communication Technology Co., Ltd | Investee Company Name | Investment Method | Investment Amount (yuan) | Shareholding Percentage | Main Business | | :--- | :--- | :--- | :--- | :--- | | Guizhou Laya Technology Co., Ltd. | Other (Acquisition and Capital Increase) | 9,088,000.00 | 80% | Medical Electronic Product R&D | | Guiyang Langma Communication Technology Co., Ltd. | New Establishment | 900,000.00 | 75% | Mobile Resale Business | [Analysis of Major Holding and Associate Companies](index=25&type=section&id=Analysis%20of%20Major%20Holding%20and%20Associate%20Companies) During the reporting period, core subsidiary Guangzhou Qisheng Information Technology Co., Ltd. (39 Health Network) contributed **42.24 million yuan** in net profit, while associate company Guiyang Pharmaceutical E-commerce Service Co., Ltd. achieved **31.02 million yuan** in net profit; the company also established Langma Communication, gained control of Guizhou Laya, and deregistered Mengcheng Interactive | Company Name | Type | Operating Revenue (yuan) | Net Profit (yuan) | | :--- | :--- | :--- | :--- | | Guangzhou Qisheng Information Technology Co., Ltd. | Subsidiary | 76,016,791.71 | 42,237,576.08 | | Guiyang Sixth People's Hospital Co., Ltd. | Subsidiary | 83,769,908.04 | -4,057,474.07 | | Guiyang Pharmaceutical E-commerce Service Co., Ltd. | Associate Company | 1,568,318,865.77 | 31,024,658.63 | | Guiyang Sanjiu Internet Medical Co., Ltd. | Associate Company | 2,406,922.28 | -7,454,655.63 | - During the reporting period, **2** new holding subsidiaries (Guizhou Laya, Langma Communication) were added, and **1** subsidiary (Mengcheng Interactive) was deregistered[84](index=84&type=chunk) [Company Risks and Countermeasures](index=27&type=section&id=Company%20Risks%20and%20Countermeasures) The company faces key risks including intensifying competition in the internet healthcare industry, changes in healthcare policies, management and operational risks due to expanding scale, and goodwill impairment risk from acquisitions, which it addresses through continuous innovation, policy monitoring, management system improvements, and post-acquisition integration - Key Risk Points: * **Increased Market Competition**: Pharmaceutical giants and internet BAT companies are entering the market, intensifying industry competition * **Industry Policy Changes**: The healthcare industry is highly susceptible to policy and regulatory changes, with stricter oversight potentially posing risks * **Management and Operational Risks**: Expanding asset and personnel scale demands higher management capabilities * **Goodwill Impairment Risk**: Goodwill arising from acquisitions carries impairment risk, necessitating enhanced subsidiary management[87](index=87&type=chunk)[88](index=88&type=chunk)[89](index=89&type=chunk) [Part V: Significant Matters](index=29&type=section&id=Part%20V%3A%20Significant%20Matters) This section details the company's fulfillment of commitments, significant related party transactions, major contracts and their performance, social responsibility initiatives, and other important events [Fulfillment of Commitments by Controlling Shareholder, Shareholders, Related Parties, Acquirers, and the Company](index=29&type=section&id=Fulfillment%20of%20Commitments%20by%20Controlling%20Shareholder%2C%20Shareholders%2C%20Related%20Parties%2C%20Acquirers%2C%20and%20the%20Company) During the reporting period, the company and relevant parties strictly fulfilled all commitments, with performance pledges (2014-2016) and related share lock-up commitments from the major asset restructuring having been completed, while the performance commitment by Pharmaceutical E-commerce General Manager Wu Wensheng for 2017-2020 is currently being fulfilled - Performance commitments and share lock-up commitments from the major asset restructuring (acquisition of Qisheng Information) have been fulfilled[94](index=94&type=chunk)[95](index=95&type=chunk) - Pharmaceutical E-commerce General Manager Wu Wensheng's performance commitment (2017-2020 revenue and net profit) is currently being fulfilled[96](index=96&type=chunk)[97](index=97&type=chunk)[98](index=98&type=chunk) [Significant Related Party Transactions](index=36&type=section&id=Significant%20Related%20Party%20Transactions) During the reporting period, the company's routine related party transactions primarily involved subsidiary Liuyi Company's procurement of pharmaceuticals and medical consumables from associate company Pharmaceutical E-commerce, totaling **23.35 million yuan**, which did not exceed the annual estimated limit of **50 million yuan**; additionally, the company co-invested in Guiyang Sanjiu Internet Medical Co., Ltd. with actual controller Wang Wei and others | Related Party | Related Transaction Content | Current Period Amount (million yuan) | Approved Transaction Limit (million yuan) | | :--- | :--- | :--- | :--- | | Guiyang Pharmaceutical E-commerce Service Co., Ltd. | Procurement of pharmaceuticals, medical consumables, etc. | 23.35 | 50 | | Guiyang Sanjiu Internet Medical Co., Ltd. | Website maintenance and labor services | 2.46 | Not applicable | [Significant Contracts and Their Performance](index=38&type=section&id=Significant%20Contracts%20and%20Their%20Performance) The company has provided multiple guarantees for its subsidiaries and associate companies; as of the end of the reporting period, the actual guarantee balance for subsidiaries was **190 million yuan**, and for associate companies' subsidiaries was **267 million yuan**, all within approved limits | Guarantee Type | Actual Guarantee Balance at Period-End (million yuan) | Percentage of Company's Net Assets | | :--- | :--- | :--- | | Guarantees for Subsidiaries | 190 | - | | Guarantees by Subsidiaries for Subsidiaries | 267 | - | | **Total Actual Guarantees** | **457** | **36.27%** | [Social Responsibility](index=41&type=section&id=Social%20Responsibility) The company actively fulfills its social responsibilities, focusing on targeted poverty alleviation; in the first half of 2018, it invested **0.11 million yuan** in funds and **0.03 million yuan** in materials across industry, education, and healthcare, helping **38** registered impoverished individuals escape poverty, and was awarded "2017 Advanced Collective for Poverty Alleviation in the City" - In the first half of the year, a cumulative **0.11 million yuan** in poverty alleviation funds and **0.03 million yuan** in material donations were invested[129](index=129&type=chunk)[130](index=130&type=chunk) - Provided internet medical services to **20** impoverished villages in Guiyang City and surrounding areas through the "Internet + Medical Poverty Alleviation" project[128](index=128&type=chunk) [Explanation of Other Significant Matters](index=44&type=section&id=Explanation%20of%20Other%20Significant%20Matters) Due to changes in market conditions, the company decided in April 2018 to terminate its public offering of convertible corporate bonds, and has received a termination of review notice from the China Securities Regulatory Commission; the convertible bonds were originally planned to raise no more than **527 million yuan** for the upgrade and expansion project of Guiyang Sixth People's Hospital - The company terminated its planned public offering of convertible corporate bonds, which aimed to raise no more than **527 million yuan**[134](index=134&type=chunk) [Part VI: Share Changes and Shareholder Information](index=46&type=section&id=Part%20VI%3A%20Share%20Changes%20and%20Shareholder%20Information) This section details changes in the company's share capital and provides information on its shareholders [Share Changes](index=46&type=section&id=Share%20Changes) During the reporting period, the company's restricted shares decreased by **9.45 million shares** due to the lifting of restrictions from a major asset restructuring, with unrestricted shares increasing accordingly; the total share capital of **337.94 million shares** remained unchanged, and the proportion of restricted shares to total share capital decreased from 42.77% to 39.97% - On January 10, 2018, **9,446,382** restricted shares from the company's major asset restructuring were released from lock-up, accounting for 2.80% of the company's total share capital[141](index=141&type=chunk) [Number of Shareholders and Shareholding Status](index=48&type=section&id=Number%20of%20Shareholders%20and%20Shareholding%20Status) As of the end of the reporting period, the company had **40,224** common shareholders, with actual controller Wang Wei holding 36.25% as the largest shareholder, and the top ten shareholders collectively holding approximately 59.52% | Shareholder Name | Shareholding Percentage | Shares Held at Period-End | Restricted Shares Held | | :--- | :--- | :--- | :--- | | Wang Wei | 36.25% | 122,496,000 | 91,872,000 | | Jin Guowen | 7.37% | 24,921,600 | 18,691,200 | | Huang Guohong | 6.80% | 22,981,086 | 19,770,375 | | Liu Ling | 4.53% | 15,312,900 | 0 | | Guiyang Langma Investment Consulting Enterprise (Limited Partnership) | 2.45% | 8,285,640 | 0 | | Shi Hongjun | 1.85% | 6,240,000 | 4,755,000 | | Gu Jing | 1.22% | 4,135,000 | 0 | | Guangzhou Xuanyuan Investment Management Co., Ltd. - Xuanyuan Fixed Increase Select | 1.00% | 3,379,414 | 0 | [Part VII: Preferred Shares Information](index=51&type=section&id=Part%20VII%3A%20Preferred%20Shares%20Information) During the reporting period, the company had no preferred shares - The company had no preferred shares during the reporting period[153](index=153&type=chunk) [Part VIII: Directors, Supervisors, and Senior Management](index=52&type=section&id=Part%20VIII%3A%20Directors%2C%20Supervisors%2C%20and%20Senior%20Management) This section provides information on the shareholding changes of the company's directors, supervisors, and senior management [Shareholding Changes of Directors, Supervisors, and Senior Management](index=52&type=section&id=Shareholding%20Changes%20of%20Directors%2C%20Supervisors%2C%20and%20Senior%20Management) During the reporting period, company director and general manager Huang Guohong reduced his holdings by **3.38 million shares**, and supervisory board chairman Shi Hongjun reduced his holdings by **0.1 million shares**; other directors, supervisors, and senior management had no changes in their shareholdings | Name | Position | Shares Reduced in Current Period (shares) | Shares Held at Period-End (shares) | | :--- | :--- | :--- | :--- | | Huang Guohong | Director, General Manager | 3,379,414 | 22,981,086 | | Shi Hongjun | Chairman of Supervisory Board | 100,000 | 6,240,000 | [Part IX: Corporate Bonds Information](index=54&type=section&id=Part%20IX%3A%20Corporate%20Bonds%20Information) During the reporting period, the company had no publicly issued corporate bonds listed on a stock exchange that were either unexpired or had matured but not been fully redeemed - The company had no publicly issued corporate bonds listed on a stock exchange that were either unexpired or had matured but not been fully redeemed as of the approval date of the semi-annual report[161](index=161&type=chunk) [Part X: Financial Report](index=55&type=section&id=Part%20X%3A%20Financial%20Report) This section contains the company's financial statements and notes for the reporting period [Audit Report](index=55&type=section&id=Audit%20Report) This semi-annual financial report is unaudited - The company's semi-annual financial report is unaudited[163](index=163&type=chunk) [Financial Statements](index=55&type=section&id=Financial%20Statements) This chapter provides the company's consolidated and parent company balance sheets, income statements, cash flow statements, and statements of changes in owners' equity for the first half of 2018 [Consolidated Balance Sheet](index=55&type=section&id=Consolidated%20Balance%20Sheet) As of June 30, 2018, the company's total assets were **1.59 billion yuan**, total liabilities were **277.61 million yuan**, and total owners' equity attributable to the parent company was **1.26 billion yuan**, resulting in a debt-to-asset ratio of 17.42% | Item | Period-End Balance (yuan) | Period-Beginning Balance (yuan) | | :--- | :--- | :--- | | Total Assets | 1,593,309,463.46 | 1,528,184,542.05 | | Total Liabilities | 277,607,959.24 | 258,588,476.24 | | Total Owners' Equity Attributable to Parent Company | 1,260,131,055.23 | 1,212,028,171.21 | [Consolidated Income Statement](index=61&type=section&id=Consolidated%20Income%20Statement) In the first half of 2018, the company achieved total operating revenue of **228.47 million yuan**, operating profit of **52.92 million yuan**, net profit of **48.02 million yuan**, with net profit attributable to parent company owners being **50.13 million yuan** | Item | Current Period Amount (yuan) | Prior Period Amount (yuan) | | :--- | :--- | :--- | | Total Operating Revenue | 228,472,570.81 | 207,584,113.81 | | Operating Profit | 52,918,170.25 | 52,641,698.57 | | Total Profit | 55,725,041.48 | 53,067,564.49 | | Net Profit | 48,015,054.26 | 43,996,384.08 | | Net Profit Attributable to Parent Company Owners | 50,134,370.92 | 48,968,125.68 | [Consolidated Cash Flow Statement](index=64&type=section&id=Consolidated%20Cash%20Flow%20Statement) During the reporting period, net cash flow from operating activities was **42.35 million yuan**, a 5.45% year-on-year increase; net cash outflow from investing activities was **74.19 million yuan**, and net cash outflow from financing activities was **2.13 million yuan**, resulting in a net decrease in cash and cash equivalents of **33.97 million yuan** | Item | Current Period Amount (yuan) | Prior Period Amount (yuan) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 42,348,247.01 | 40,160,073.06 | | Net Cash Flow from Investing Activities | -74,187,957.70 | -93,652,025.96 | | Net Cash Flow from Financing Activities | -2,131,776.07 | 36,031,849.21 | | Net Increase in Cash and Cash Equivalents | -33,971,486.76 | -17,460,103.69 | [Notes to Consolidated Financial Statements](index=112&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) This chapter provides detailed explanations of major items in the consolidated financial statements, including the composition, changes, and specific breakdowns of monetary funds, accounts receivable, long-term equity investments, goodwill, operating revenue and costs, and investment income [Accounts Receivable](index=113&type=section&id=Accounts%20Receivable) At period-end, the book value of accounts receivable was **97.52 million yuan**, a 28.98% increase from the beginning of the period, with 82.52% concentrated in accounts less than 6 months old, and the top five customers accounting for 39.22% of the total | Aging | Period-End Balance (yuan) | Percentage | | :--- | :--- | :--- | | Within 6 months | 82,520,666.07 | 81.95% | | 6 months - 1 year | 11,328,302.33 | 11.25% | | 1-2 years | 3,891,780.19 | 3.86% | | Over 2 years | 2,956,266.40 | 2.94% | | **Total** | **100,698,014.99** | **100.00%** | [Long-Term Equity Investments](index=119&type=section&id=Long-Term%20Equity%20Investments) At period-end, the book value of long-term equity investments was **273.37 million yuan**, primarily in associate companies; during the period, **10.64 million yuan** in investment income was recognized from Guiyang Pharmaceutical E-commerce Service Co., Ltd., and a cash dividend of **17.15 million yuan** was declared | Investee Unit | Period-Beginning Balance (yuan) | Investment Gains/Losses under Equity Method in Current Period (yuan) | Period-End Balance (yuan) | | :--- | :--- | :--- | :--- | | Guiyang Pharmaceutical E-commerce Service Co., Ltd. | 242,087,159.96 | 10,641,457.91 | 235,578,617.87 | | Guiyang Sanjiu Internet Medical Co., Ltd. | 14,469,211.11 | -1,504,349.51 | 12,964,861.60 | | **Subtotal for Associate Companies** | **279,309,597.63** | **9,018,399.61** | **269,631,245.30** | [Goodwill](index=124&type=section&id=Goodwill) At period-end, the original book value of goodwill was **577 million yuan**, primarily from the acquisition of Guangzhou Qisheng Information Technology Co., Ltd. (**570 million yuan**) and Guiyang Sixth People's Hospital Co., Ltd. (**6.47 million yuan**); during the period, **0.50 million yuan** in goodwill was written off due to the deregistration of subsidiary Mengcheng Interactive - Due to the deregistration of subsidiary Guiyang Mengcheng Interactive Technology Co., Ltd., its corresponding original goodwill value of **496,911.93 yuan** and impairment provision of **496,911.93 yuan** were both written off in the current period[378](index=378&type=chunk)[380](index=380&type=chunk) [Operating Revenue and Operating Costs](index=137&type=section&id=Operating%20Revenue%20and%20Operating%20Costs) In the first half of 2018, the company achieved **225 million yuan** in main business revenue and **106 million yuan** in main business costs, with other business revenue totaling **3.76 million yuan** | Item | Current Period Amount (yuan) | Prior Period Amount (yuan) | | :--- | :--- | :--- | | **Revenue** | | | | Main Business | 224,717,295.30 | 204,794,062.31 | | Other Business | 3,755,275.51 | 2,790,051.50 | | **Costs** | | | | Main Business | 106,336,808.97 | 90,063,103.06 | | Other Business | 2,189,681.70 | 4,425,052.50 | [Part XI: Documents for Reference](index=163&type=section&id=Part%20XI%3A%20Documents%20for%20Reference) This chapter lists the reference documents available for inspection, including the original semi-annual report text signed by the legal representative and the financial report signed and sealed by relevant responsible persons, all kept at the company's securities department

贵阳朗玛信息技术股份有限公司 2017 年年度报告全文 贵阳朗玛信息技术股份有限公司 2017 年年度报告 2018 年 04 月 1 贵阳朗玛信息技术股份有限公司 2017 年年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连 带的法律责任。 公司负责人王伟、主管会计工作负责人王春及会计机构负责人(会计主管人 员)马勇声明：保证年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本报告中如有涉及未来的计划、业绩预测等方面的内容，均不构成本公司 对任何投资者及相关人士的承诺。投资者及相关人士均应对此保持足够的风险 认识，并且应当理解计划、预测与承诺之间的差异。公司在本报告第四节"经营 情况讨论与分析"之"九、公司未来发展的展望"部分，详细描述了公司经营中可 能存在的风险，敬请投资者关注相关内容，注意投资风险。 1、市场竞争加剧风险 中国整体宏观环境的变化、社会老龄化的到来，医疗健康服务业将成为未 来国民经济的亮点。国家医疗卫生体制改革进一步深化，"互联 ...

贵阳朗玛信息技术股份有限公司 2018 年第一季度报告全文 贵阳朗玛信息技术股份有限公司 2018 年第一季度报告 2018 年 04 月 1 贵阳朗玛信息技术股份有限公司 2018 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人王伟、主管会计工作负责人王春及会计机构负责人（会计主管 人员）马勇声明：保证季度报告中财务报表的真实、准确、完整。 2 公司是否需追溯调整或重述以前年度会计数据 贵阳朗玛信息技术股份有限公司 2018 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 | | 本报告期 | 上年同期 | 本报告期比上年同期 | | --- | --- | --- | --- | | | | | 增减 | | 营业总收入（元） | 105,717,302.57 | 98,412,442.24 | 7.42% | | 归属于上市公司股东的净利润（元） | 21,472,892.33 | ...

贵阳朗玛信息技术股份有限公司 2017 年半年度报告全文 贵阳朗玛信息技术股份有限公司 2017 年半年度报告（修正后） 2018 年 04 月 1 贵阳朗玛信息技术股份有限公司 2017 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的 真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别 和连带的法律责任。 公司负责人王伟、主管会计工作负责人王春及会计机构负责人(会计主管人 员)马勇声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 本报告中如有涉及未来的计划、业绩预测等方面的内容，均不构成本公司 对任何投资者及相关人士的承诺。投资者及相关人士均应对此保持足够的风险 认识，并且应当理解计划、预测与承诺之间的差异。公司在本报告第四节"经营 情况讨论与分析"之"十、公司面临的风险和应对措施"部分，详细描述了公司经 营中可能存在的风险，敬请投资者关注相关内容，注意投资风险。 1、市场竞争加剧风险 中国整体宏观环境的变化、社会老龄化的到来，医疗健康产业具备较好的 前景。国家医疗卫生体制 ...

贵阳朗玛信息技术股份有限公司 2017 年第三季度报告（修正后） 2018 年 4 月 贵阳朗玛信息技术股份有限公司 2017 年第三季度报告全文 1 贵阳朗玛信息技术股份有限公司 2017 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人王伟、主管会计工作负责人王春及会计机构负责人(会计主管人 员)马勇声明：保证季度报告中财务报表的真实、准确、完整。 2 贵阳朗玛信息技术股份有限公司 2017 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 □ 是 √ 否 | | 本报告期末 | | 上年度末 | 本报告期末比上年 度末增减 | | --- | --- | --- | --- | --- | | 总资产（元） | 1,451,646,781.05 | | 1,369,860,816.34 | 5.97% | | 归属于上市公司股东的净资产（元） | 1,209,283,265.36 | | ...

贵阳朗玛信息技术股份有限公司 2017 年年度报告全文 贵阳朗玛信息技术股份有限公司 2017 年年度报告 2018 年 04 月 1 贵阳朗玛信息技术股份有限公司 2017 年年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连 带的法律责任。 公司负责人王伟、主管会计工作负责人王春及会计机构负责人(会计主管人 员)马勇声明：保证年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本报告中如有涉及未来的计划、业绩预测等方面的内容，均不构成本公司 对任何投资者及相关人士的承诺。投资者及相关人士均应对此保持足够的风险 认识，并且应当理解计划、预测与承诺之间的差异。公司在本报告第四节"经营 情况讨论与分析"之"九、公司未来发展的展望"部分，详细描述了公司经营中可 能存在的风险，敬请投资者关注相关内容，注意投资风险。 1、市场竞争加剧风险 中国整体宏观环境的变化、社会老龄化的到来，医疗健康服务业将成为未 来国民经济的亮点。国家医疗卫生体制改革进一步深化，"互联 ...